Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 12/20/2021
Holiday quiz: Drug names
All of the following pairs of drug name are considered to be synonyms, EXCEPT for . . . - 12/19/2021
Helping patients with rheumatoid arthritis transition from biologics to other drugs
Monitoring algorithm for pharmacists facilitates switching from originator biologics to other originator biologics, biosimilars or Janus kinase inhibitors. - 12/15/2021
How to optimize bone health in men receiving androgen deprivation therapy
Canadian Urological Association provides recommendations for maintaining bone health in men with prostate cancer receiving ADT - 12/13/2021
Help prevent methotrexate toxicity from unintentional dosing errors
Accidental duplicate ingestions by patients and healthcare professional errors are the most common unintentional errors. - 12/13/2021
Review identifies slip ups that lead to methotrexate toxicity from unintentional dosing errors
Accidental duplicate ingestions by patients and healthcare professional errors are the most common unintentional errors. - 12/8/2021
Managing hyperkalemia caused by renin-angiotensin-aldosterone system inhibitors
Strategies to reduce the risk of chronic hyperkalemia in patients being treated with RAAS inhibitors for chronic kidney disease, heart failure and other conditions - 12/5/2021
How should chronic cough be assessed and managed?
Canadian review highlights recommended investigations, current management options and new treatments under study for chronic cough - 12/1/2021
Long-acting injectable antipsychotics for schizophrenia are underutilized in Canada
Despite their ability to improve adherence, study finds that long-acting injectable antipsychotics are often not started until years after diagnosis. - 11/29/2021
Unique aspects and manifestations of cardiovascular disease in women
Canadian Women’s Heart Health Alliance adds new chapter to Atlas, focusing on unique aspects and manifestations of CVD in women. - 11/23/2021
Is sotrovimab neutralizing antibody for early COVID-19 available in Canada?
GSK continues to work with provinces and territories to make sotrovimab available to appropriate patients.
